Julio Sevillano1, María Gracia Sánchez-Alonso1, Begoña Zapatería1, María Calderón1, Martín Alcalá1, María Limones1, Jimena Pita1, Esther Gramage2, Marta Vicente-Rodríguez2, Daniel Horrillo3, Gema Medina-Gómez3, María Jesús Obregón4, Marta Viana1, Ismael Valladolid-Acebes5, Gonzalo Herradón2, María Pilar Ramos-Álvarez6. 1. Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Ctra. Boadilla del Monte km 5,3, 28668, Madrid, Spain. 2. Department of Pharmaceutical and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, Spain. 3. Department of Basic Sciences of Health, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain. 4. Department of Endocrine and Nervous System Pathophysiology, Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain. 5. The Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 6. Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Ctra. Boadilla del Monte km 5,3, 28668, Madrid, Spain. pramos@ceu.es.
Abstract
AIMS/HYPOTHESIS: Pleiotrophin, a developmentally regulated and highly conserved cytokine, exerts different functions including regulation of cell growth and survival. Here, we hypothesise that this cytokine can play a regulatory role in glucose and lipid homeostasis. METHODS: To test this hypothesis, we performed a longitudinal study characterising the metabolic profile (circulating variables and tissue mRNA expression) of gene-targeted Ptn-deficient female mice and their corresponding wild-type counterparts at different ages from young adulthood (3 months) to older age (15 months). Metabolic cages were used to investigate the respiratory exchange ratio and energy expenditure, at both 24°C and 30°C. Undifferentiated immortalised mouse brown adipocytes (mBAs) were treated with 0.1 μg/ml pleiotrophin until day 6 of differentiation, and markers of mBA differentiation were analysed by quantitative real-time PCR (qPCR). RESULTS: Ptn deletion was associated with a reduction in total body fat (20.2% in Ptn+/+ vs 13.9% in Ptn-/- mice) and an enhanced lipolytic response to isoprenaline in isolated adipocytes from 15-month-old mice (189% in Ptn+/+ vs 273% in Ptn-/- mice). We found that Ptn-/- mice exhibited a significantly lower QUICKI value and an altered lipid profile; plasma triacylglycerols and NEFA did not increase with age, as happens in Ptn+/+ mice. Furthermore, the contribution of cold-induced thermogenesis to energy expenditure was greater in Ptn-/- than Ptn+/+ mice (42.6% and 33.6%, respectively). Body temperature and the activity and expression of deiodinase, T3 and mitochondrial uncoupling protein-1 in the brown adipose tissue of Ptn-/- mice were higher than in wild-type controls. Finally, supplementing brown pre-adipocytes with pleiotrophin decreased the expression of the brown adipocyte markers Cidea (20% reduction), Prdm16 (21% reduction), and Pgc1-α (also known as Ppargc1a, 11% reduction). CONCLUSIONS/ INTERPRETATION: Our results reveal for the first time that pleiotrophin is a key player in preserving insulin sensitivity, driving the dynamics of adipose tissue lipid turnover and plasticity, and regulating energy metabolism and thermogenesis. These findings open therapeutic avenues for the treatment of metabolic disorders by targeting pleiotrophin in the crosstalk between white and brown adipose tissue.
AIMS/HYPOTHESIS: Pleiotrophin, a developmentally regulated and highly conserved cytokine, exerts different functions including regulation of cell growth and survival. Here, we hypothesise that this cytokine can play a regulatory role in glucose and lipid homeostasis. METHODS: To test this hypothesis, we performed a longitudinal study characterising the metabolic profile (circulating variables and tissue mRNA expression) of gene-targeted Ptn-deficient female mice and their corresponding wild-type counterparts at different ages from young adulthood (3 months) to older age (15 months). Metabolic cages were used to investigate the respiratory exchange ratio and energy expenditure, at both 24°C and 30°C. Undifferentiated immortalised mouse brown adipocytes (mBAs) were treated with 0.1 μg/ml pleiotrophin until day 6 of differentiation, and markers of mBA differentiation were analysed by quantitative real-time PCR (qPCR). RESULTS:Ptn deletion was associated with a reduction in total body fat (20.2% in Ptn+/+ vs 13.9% in Ptn-/- mice) and an enhanced lipolytic response to isoprenaline in isolated adipocytes from 15-month-old mice (189% in Ptn+/+ vs 273% in Ptn-/- mice). We found that Ptn-/- mice exhibited a significantly lower QUICKI value and an altered lipid profile; plasma triacylglycerols and NEFA did not increase with age, as happens in Ptn+/+ mice. Furthermore, the contribution of cold-induced thermogenesis to energy expenditure was greater in Ptn-/- than Ptn+/+ mice (42.6% and 33.6%, respectively). Body temperature and the activity and expression of deiodinase, T3 and mitochondrial uncoupling protein-1 in the brown adipose tissue of Ptn-/- mice were higher than in wild-type controls. Finally, supplementing brown pre-adipocytes with pleiotrophin decreased the expression of the brown adipocyte markers Cidea (20% reduction), Prdm16 (21% reduction), and Pgc1-α (also known as Ppargc1a, 11% reduction). CONCLUSIONS/ INTERPRETATION: Our results reveal for the first time that pleiotrophin is a key player in preserving insulin sensitivity, driving the dynamics of adipose tissue lipid turnover and plasticity, and regulating energy metabolism and thermogenesis. These findings open therapeutic avenues for the treatment of metabolic disorders by targeting pleiotrophin in the crosstalk between white and brown adipose tissue.
Authors: Janica C Wong; Katherine C Krueger; Maria José Costa; Abhishek Aggarwal; Hongqing Du; Tracey L McLaughlin; Brian J Feldman Journal: Sci Signal Date: 2016-10-25 Impact factor: 8.192
Authors: L E Amet; S E Lauri; A Hienola; S D Croll; Y Lu; J M Levorse; B Prabhakaran; T Taira; H Rauvala; T F Vogt Journal: Mol Cell Neurosci Date: 2001-06 Impact factor: 4.314
Authors: Chek Kun Tan; Nicolas Leuenberger; Ming Jie Tan; Yew Wai Yan; Yinghui Chen; Ravi Kambadur; Walter Wahli; Nguan Soon Tan Journal: Diabetes Date: 2011-02 Impact factor: 9.461
Authors: María Calderon-Dominguez; David Sebastián; Raquel Fucho; Minéia Weber; Joan F Mir; Ester García-Casarrubios; María Jesús Obregón; Antonio Zorzano; Ángela M Valverde; Dolors Serra; Laura Herrero Journal: PLoS One Date: 2016-07-20 Impact factor: 3.240
Authors: T A Mitsiadis; M Salmivirta; T Muramatsu; H Muramatsu; H Rauvala; E Lehtonen; M Jalkanen; I Thesleff Journal: Development Date: 1995-01 Impact factor: 6.868
Authors: Laura Buggiotti; Andrey A Yurchenko; Nikolay S Yudin; Christy J Vander Jagt; Nadezhda V Vorobieva; Mariya A Kusliy; Sergei K Vasiliev; Andrey N Rodionov; Oksana I Boronetskaya; Natalia A Zinovieva; Alexander S Graphodatsky; Hans D Daetwyler; Denis M Larkin Journal: Mol Biol Evol Date: 2021-07-29 Impact factor: 16.240
Authors: Julio Sevillano; Aileen Liang; Brenda Strutt; Thomas G Hill; Sandra Szlapinski; Maria Pilar Ramos-Álvarez; David J Hill Journal: Front Endocrinol (Lausanne) Date: 2022-02-18 Impact factor: 5.555
Authors: Julio Sevillano; María Gracia Sánchez-Alonso; Javier Pizarro-Delgado; María Del Pilar Ramos-Álvarez Journal: Int J Mol Sci Date: 2021-05-28 Impact factor: 5.923